Поисковый запрос: (<.>A=Woosley, Raymond$<.>) |
Общее количество найденных документов : 20
Показаны документы с 1 по 20
|
1.
| Woosley Raymond L. Cardiac actions of antihistamines // Annu. Rev. Pharmacol. and Toxicol.. -Palo Alto (Calif.), 1996, Vol. 36.-С.233-252
|
2.
| Determination of clemastine in human plasma by gas chromatography with nitrogen-phosphorus detection // J Chromatgr. B, 2000. Vol. 744, N 1.-С.177-181
|
3.
| Determination of clemastine in human plasma by gas chromatography with nitrogen-phosphorus detection // J Chromatgr. B, 2000. Vol. 744, N 1.-С.177-181
|
4.
| Olanzapine-induced rhabdomyolysis // Ann. Pharmacother., 2001. Vol. 35, N 9.-С.1020-1023
|
5.
| MinK differentially modulates HERG blockade by various neuroleptics // Biophys. J., 2001. Vol. 80, N 1.-С.215-216
|
6.
| Woosley Raymond L. Discovering adverse reactions: Why does it take so long? // Clin. Pharmacol. and Ther., 2004. Vol. 76, N 4.-С.287-289
|
7.
| Woosley Raymond L. Discovering adverse reactions: Why does it take so long? // Clin. Pharmacol. and Ther., 2004. Vol. 76, N 4.-С.287-289
|
8.
| Comparative evaluation of HERG currents and QT intervals following challenge with suspected torsadogenic and nontorsadogenic drugs // J. Pharmacol. and Exp. Ther., 2006. Vol. 316, N 3.-С.1098-1106
|
9.
| Woodcock The FDS critical path initiative and its influence on new drug development // Annual Review of Medicine. Vol.59.2008. -Palo Alto (Calif.), 2008.-С.1-12
|
10.
| The development and testing of intravenous dosing regimens: Application to flecainide for the suppression of ventricular arrhythmias // Clin. Pharmacol. and Ther., 1988. Vol. 43, N 5.-С.499-508
|
11.
| Stereoselective disposition and pharmacologic activity of propafenone enantiomers // Circulation, 1989. Vol. 79, N 5.-С.1068-1076
|
12.
| Woosley Polymorphic drug oxidation: therapeutic implications // Eur. J. Clin. Pharmacol., 1989. Vol. 36, Suppl..-С.6
|
13.
| Mexiletine and tocainide: A comparison of antiarrhythmic efficacy, adverse effestc, and predictive value of lidocaine testing // Clin. Pharmacol. and Ther, 1989. Vol. 45, N 5.-С.553-561
|
14.
| Recainam dose titration and pharmacokinetics in patients with resistant arrhythmias // Clin. Pharmacol. and Ther., 1989. Vol. 46, N 3.-С.324-334
|
15.
| Bajaj Ashok K. Acute electrophysiologic effects of sodium adminisration in dogs treated with O-desmethyl encainide // Circulation, 1989. Vol. 80, N 4.-С.994-1002
|
16.
| Efficacy and safety of ACC-9358, a new antiarrhythmic agent // Amer. J. Cardiol., 1990. Vol. 65, N 13.-С.932-934
|
17.
| Clinical pharmacokinetics of moricizine // Amer. J. Cardiol., 1990. Vol. 65, N 8.-С.21-25
|
18.
| Antiarrhythmic efficacy, clinical elejtrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia of fibrillation // Circulation, 1989. Vol. 80, N 5.-С.1247-1258
|
19.
| A mechanism of D-(+)-sotalol effects on heart rate not related to 'бета'-adrenoceptor antagonism // Brit. J. Clin. Pharmacol., 1990. Vol. 30, N 2.-С.195-202
|
20.
| Concentration/response relations for the multiple antiarrhythmic actions of sotalol // Amer. J. Cardiol., 1990. Vol. 65, N 2.-С.22-27
|
&uf('+1W2226#',v2226), ?>
|